Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
39 hedge funds and large institutions have $157M invested in Kindred Biosciences, Inc. in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 8 closing their positions.
238% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 8
95% more funds holding
Funds holding: 20 → 39 (+19)
71% more capital invested
Capital invested by funds: $91.5M → $157M (+$65.3M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.04M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.5M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$4.01M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.88M |
| 5 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$1.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.24M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$3.37M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
-$2.6M |
| 4 |
DM
Deerfield Management
New York
|
-$2.51M |
| 5 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$1.31M |
KIN Hedge Fund Activity: Q1 2014 in Review
39 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2014, worth a combined $157M — up 71% from $91.5M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new KIN positions and 8 closed out — a net gain of 19 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $5.04M. The largest seller was Adage Capital Partners, cutting an estimated $5.24M.
- 39 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2014, up from 20 in Q4 2013.
- Funds reported $157M of Kindred Biosciences, Inc. stock for Q1 2014, up 71% quarter-over-quarter.
- 27 funds opened new Kindred Biosciences, Inc. positions in Q1 2014 and 8 closed out, a net change of +19 holders.
- The largest Kindred Biosciences, Inc. buyer in Q1 2014 was Fidelity Investments, an estimated $5.04M added.
- The largest Kindred Biosciences, Inc. seller in Q1 2014 was Adage Capital Partners, an estimated $5.24M sold.
Based on aggregated 13F filings for Q1 2014.